Načítá se...
Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes chronic cognitive dysfunction. Most of the AD cases are late onset, and the apolipoprotein E (APOE) isoform is a key genetic risk factor. The APOE gene has 3 key alleles in humans including APOE2, APOE3, and APOE4....
Uloženo v:
Vydáno v: | Oxid Med Cell Longev |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Hindawi
2020
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7245681/ https://ncbi.nlm.nih.gov/pubmed/32509144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5086250 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|